111 related articles for article (PubMed ID: 898127)
1. [Pharmacokinetic and metabolic study of disopyramide in oral and intravenous administration].
De Graeve J; Kremers P; Gielen JE
Therapie; 1977; 32(2):195-204. PubMed ID: 898127
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of disopyramide administered by intramuscular, intravenous and oral routes to normal volunteers [proceedings].
Ashford JJ; Carmichael D; Kidner PH
Br J Pharmacol; 1979 Jul; 66(3):442P-443P. PubMed ID: 526732
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog.
Karim A; Kook C; Novotney RL; Zagarella J; Campion J
Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556
[TBL] [Abstract][Full Text] [Related]
4. Disopyramide phosphate: tissue uptake and relationship between drug concentrations in the plasma and myocardium of rats.
Karim A; Kook C; Campion J; Doherty M
Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):222-36. PubMed ID: 921413
[TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics of Norpace.
Karim A
Angiology; 1975 Jan; 26(1 Pt 2):85-98. PubMed ID: 1090217
[No Abstract] [Full Text] [Related]
6. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans.
Aitio ML; Allonen H; Kanto J; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921
[TBL] [Abstract][Full Text] [Related]
7. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability.
Bryson SM; Whiting B; Lawrence JR
Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of disopyramide following myocardial infarction with special reference to oral and intravenous dose regimens.
Ward JW; Kinghorn GR
J Int Med Res; 1976; 4(1 Suppl):49-53. PubMed ID: 1026529
[No Abstract] [Full Text] [Related]
9. Disopyramide kinetics in patients with acute myocardial infarction.
Ilett KF; Madsen BW; Woods JD
Clin Pharmacol Ther; 1979 Jul; 26(1):1-7. PubMed ID: 445953
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacokinetic study of disopyramide in normal man].
Mallein R; Rondelet J; Boucherat M; Ksavrelof M; Pignat M
Therapie; 1978; 33(4):463-73. PubMed ID: 734626
[No Abstract] [Full Text] [Related]
11. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
12. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide.
Cunningham JL; Shen DD; Shudo I; Azarnoff DL
Clin Pharmacokinet; 1977; 2(5):373-83. PubMed ID: 21054
[TBL] [Abstract][Full Text] [Related]
13. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
Hulting J; Rosenhamer G
J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
[No Abstract] [Full Text] [Related]
14. Disopyramide pharmacokinetics and bioavailability.
Dubetz DK; Brown NN; Hooper WD; Eadie MJ; Tyrer JH
Br J Clin Pharmacol; 1978 Sep; 6(3):279-81. PubMed ID: 687507
[No Abstract] [Full Text] [Related]
15. Disopyramide in renal impairment.
Whiting B; Elliott HL
Lancet; 1977 Dec 24-31; 2(8052-8053):1363. PubMed ID: 74774
[No Abstract] [Full Text] [Related]
16. The absorption of disopyramide in animals determined using a stable isotope co-administration technique.
Haskins NJ; Waddell KA; Ford GC; Spalton PN; Walls CM; Forrest TJ; Palmer RF
Biomed Mass Spectrom; 1980 Feb; 7(2):80-3. PubMed ID: 7407335
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of disopyramide in patients with acute myocardial infarction.
Jounela AJ; Pentikäinen PJ; Oksanen K
Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):276-82. PubMed ID: 7107076
[TBL] [Abstract][Full Text] [Related]
18. Species differences in the biotransformation of a new antiarrhythmic agent: disopyramide phosphate.
Karim A; Ranney RE; Kraychy S
J Pharm Sci; 1972 Jun; 61(6):888-93. PubMed ID: 5046104
[No Abstract] [Full Text] [Related]
19. Disopyramide phosphate: pharmacokinetic and pharmacologic relationships of a new antiarrhythmic agent.
Ranney RE; Dean RR; Karim A; Radzialowski FM
Arch Int Pharmacodyn Ther; 1971 May; 191(1):162-88. PubMed ID: 4104224
[No Abstract] [Full Text] [Related]
20. Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis.
Sevka MJ; Matthews SJ; Nightingale CH; Izard MW; Fieldman A; Chow MS
Clin Pharmacol Ther; 1981 Mar; 29(3):322-6. PubMed ID: 7471602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
